Borui Kang

From Pure Antagonists to Pure Degraders of the Estrogen Receptor: Evolving Strategies for the Same Target

Madhusoodanan Mottamal, Guangdi Wang, Borui Kang, 2021, ACS omega.

Design and synthesis of a novel ZB716-d6 as a stable isotopically labeled internal standard

Shilong Zheng, Guangdi Wang, Borui Kang, 2022, Synthetic communications.

Fulvestrant-3-Boronic Acid (ZB716) Demonstrates Oral Bioavailability and Favorable Pharmacokinetic Profile in Preclinical ADME Studies

Jiawang Liu, Shanchun Guo, H. Jung, 2021, Pharmaceuticals.

Design, Synthesis, and Evaluation of Niclosamide Analogs as Therapeutic Agents for Enzalutamide-Resistant Prostate Cancer

Shanchun Guo, Florastina Payton-Stewart, M. Bratton, 2023, Pharmaceuticals.